{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-277",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/regulation-277.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "regulation/277",
  "kind": "regulation",
  "number": "277",
  "heading": "Interpretation",
  "text": "(1) In this Part—\n“court” means the High Court or, in Scotland, the Court of Session;\n“holder of a temporary authorisation” means, where there is in force in relation to a medicinal product an authorisation by the licensing authority on a temporary basis under regulation 174 (but not an authorisation, certificate or registration as mentioned in regulation 281(1)(a) to (e)), the person who is responsible for placing that product on the market in the United Kingdom;\n“injunction” (except in regulation 313) includes an interim injunction;\n“OFCOM” means the Office of Communications;\n“person qualified to prescribe or supply medicinal products” includes—\n(a)persons who, in the course of their profession or in the course of a business, may lawfully—\n(i)prescribe medicinal products,\n(ii)sell medicinal products by retail, or\n(iii)supply medicinal products in circumstances corresponding to retail sale; and\n(b)employees of such persons;\n“publication”, in relation to an advertisement, means the dissemination or issue of that advertisement—\n(a)orally;\n(b)in writing;\n(c)by means of an electronic communications network within the meaning of the Communications Act 2003 ; or\n(d)in any other way,\nand includes causing or procuring such publication by or on behalf of another person, and “publish” has a corresponding meaning.\n(2) In the application of this Part to Scotland—\n(a) references to an injunction are to be read as references to an interdict; and\n(b) references to an interim injunction are to be read as references to an interim interdict.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in reg. 277(1) inserted (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.I. 2020/1125), regs. 1(2), 16 and words in reg. 277(1) inserted (N.I.) (6.11.2020) by The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (S.R. 2020/349), regs. 1(2), 16"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in reg. 277(1) substituted (31.12.2020 immediately after S.I. 2019/775 comes into force) by The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 (S.I. 2020/1594), regs. 1(3), 10 and The Human Medicines (Coronavirus) (Further Amendments) Regulations 2020 (S.R. 2020/350), regs. 1(3), 10"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "2003 c.21."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/regulation/277",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}